drugset / Trial / NCT00003710
Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors
Phase 1
Completed
12 enrolled
The University of Texas Health Science Center at San Antonio
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of irinotecan plus mitomycin in treating patients who have advanced solid tumors that are persistent or recurrent.
Timeline
- Start
- 1998-08
- Primary completion
- 2001-05
- Completion
- 2001-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | — | Intravenous |
| Subject | Mitomycin C | Other / unclassified | — | Intravenous |